Atlas Trials

Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334

Clinical trial NCT04086602 · COMPLETED

Trial details

NCT number
NCT04086602
Sponsor
Inflazome UK Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy VolunteersCryopyrin Associated Periodic Syndrome
Start date
2019-09-13
Primary completion
2020-02-04
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.